WELL Health Technologies Corp.

TSX:WELL Stok Raporu

Piyasa değeri: CA$1.1b

WELL Health Technologies Yönetim

Yönetim kriter kontrolleri 3/4

WELL Health Technologies' CEO is Hamed Shahbazi, appointed in May 2018, has a tenure of 6.5 years. total yearly compensation is CA$6.51M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 5.97% of the company’s shares, worth CA$65.22M. The average tenure of the management team and the board of directors is 5.6 years and 6.6 years respectively.

Anahtar bilgiler

Hamed Shahbazi

İcra Kurulu Başkanı

CA$6.5m

Toplam tazminat

CEO maaş yüzdesi7.7%
CEO görev süresi6.5yrs
CEO sahipliği6.0%
Yönetim ortalama görev süresi5.6yrs
Yönetim Kurulu ortalama görev süresi6.6yrs

Son yönetim güncellemeleri

Recent updates

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09
Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05
Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11
WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

May 21
WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Mar 21
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Feb 29
Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

Jan 18
The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Oct 30
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Jul 17
We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Apr 18
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Jan 13
Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

Nov 11
Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

Aug 09
Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

May 31
WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

CEO Tazminat Analizi

Hamed Shahbazi'un ücretlendirmesi WELL Health Technologies'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

CA$147m

Mar 31 2024n/an/a

CA$30m

Dec 31 2023CA$7mCA$500k

CA$82k

Sep 30 2023n/an/a

-CA$7m

Jun 30 2023n/an/a

-CA$4m

Mar 31 2023n/an/a

-CA$5m

Dec 31 2022CA$2mCA$450k

CA$1m

Sep 30 2022n/an/a

-CA$29m

Jun 30 2022n/an/a

-CA$37m

Mar 31 2022n/an/a

-CA$45m

Dec 31 2021CA$5mn/a

-CA$44m

Sep 30 2021n/an/a

-CA$29m

Jun 30 2021n/an/a

-CA$21m

Mar 31 2021n/an/a

-CA$9m

Dec 31 2020CA$710kn/a

-CA$4m

Sep 30 2020n/an/a

-CA$9m

Jun 30 2020n/an/a

-CA$10m

Mar 31 2020n/an/a

-CA$8m

Dec 31 2019CA$681kn/a

-CA$8m

Dec 31 2018CA$502kn/a

-CA$2m

Tazminat ve Piyasa: Hamed's total compensation ($USD4.66M) is above average for companies of similar size in the Canadian market ($USD1.83M).

Tazminat ve Kazançlar: Hamed's compensation has been consistent with company performance over the past year.


CEO

Hamed Shahbazi (49 yo)

6.5yrs

Görev süresi

CA$6,508,755

Tazminat

Mr. Hamed Shahbazi, B. Sc., serves as Chairman & Chief Executive Officer at WELL Ventures. He is Chairman of the Board of Healwell AI Inc. from February 2024. He was Director of Healwell AI Inc. from Octob...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Hamed Shahbazi
Founder6.5yrsCA$6.51m5.97%
CA$ 65.2m
Eva Fong
Chief Financial Officer5.6yrsCA$1.15m0.70%
CA$ 7.6m
Amir Javidan
Chief Operating Officer5.8yrsCA$1.12m0.80%
CA$ 8.8m
James Kreger
CEO of WELL Health USA & CRH Medical2.8yrsCA$1.64mVeri yok
Beemal Shah
COO of CRH Medical Corporation2.2yrsCA$1.58mVeri yok
Pardeep Sangha
Vice President of Corporate Strategy & Investor Relations5.6yrsVeri yokVeri yok
Brian Levinkind
Senior Vice President of Corporate Development5.6yrsCA$302.30kVeri yok
Chris Ericksen
Senior Vice President of Strategic Partnerships & Marketing5.8yrsVeri yokVeri yok
Shane Sabatino
Chief People Officer3.8yrsVeri yokVeri yok
Michael Frankel
Chief Medical Officer6yrsCA$639.73kVeri yok
Michael Goodman
Head of Acquisitions - Eastern Canada4.3yrsVeri yokVeri yok
Iain Paterson
Chief Information Security Officer2.5yrsVeri yokVeri yok

5.6yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: WELL's management team is seasoned and experienced (5.6 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Hamed Shahbazi
Founder8.7yrsCA$6.51m5.97%
CA$ 65.2m
Thomas Liston
Independent Director6.6yrsCA$257.87k0.26%
CA$ 2.8m
Kenneth Cawkell
Independent Director8.7yrsCA$245.50k0.18%
CA$ 2.0m
John Kim
Independent Director6.8yrsCA$245.50k0.15%
CA$ 1.7m
Patricia Kirkpatrick
Member of Advisory Board5.2yrsVeri yokVeri yok
Tara McCarville
Independent Director4.6yrsCA$245.50k0.039%
CA$ 422.9k
Sybil E. Lau
Independent Director2.3yrsCA$210.24k0.20%
CA$ 2.2m

6.6yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: WELL's board of directors are considered experienced (6.6 years average tenure).